
Pharmaceutical giant Pfizer Inc., through its wholly-owned subsidiary Biohaven Pharmaceutical Holding Company Ltd., has agreed to pay $59.7 million to settle allegations that Biohaven violated the anti-kickback statute by paying improper incentives to healthcare providers to prescribe its migraine medication, Nurtec ODT. The settlement resolves claims that Biohaven knowingly caused... Read More »